Overview
ModivCare Inc. is a healthcare services company based in the United States, specifically in Denver, Colorado. Operating primarily in the healthcare industry, ModivCare offers a diverse range of integrated care solutions that are designed to improve patient outcomes and care continuity. Its services notably include non-emergency medical transportation (NEMT), remote patient monitoring, and nutritional meal delivery, all geared towards enhancing access to care for underserved communities. A key aspect of ModivCare’s operations is its focus on leveraging technology and network management to optimize service delivery and patient satisfaction, marking it as a prominent player in the sector of heathcare logistics and support services. The company plays a crucial role in addressing the social determinants of health by ensuring that mobility and nutritional needs are not barriers to receiving healthcare.
AI+ Ask Fintel’s AI assistant about ModivCare Inc..
Thinking about good questions…
Basic Stats
The Factor Analysis chart (below right) shows a view of ModivCare Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 14.33 MM |
| Earnings Date | |
| EPS (TTM) | -16.01 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | 375.39 |
| Short Shares Avail. | 0.02 MM |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | -0.14 |
| ROE | -24.10 |
| ROIC | -0.17 |
| CROIC | 0.08 |
| OCROIC | -0.07 |
| Implied Volatility | 0.00 % |
| Put/Call OI Ratio | 2.31 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for ModivCare Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2025-05-12 | Barrington Research | Outperform | Market Perform | Downgrade |
| 2025-03-10 | Stephens & Co. | Equal-Weight | Equal-Weight | Maintains |
| 2025-03-07 | Barrington Research | Outperform | Outperform | Maintains |
| 2025-01-14 | Barrington Research | Outperform | Outperform | Maintains |
| 2025-01-13 | Lake Street | Buy | Buy | Maintains |
| 2025-01-10 | Stephens & Co. | Overweight | Equal-Weight | Downgrade |
| 2024-11-18 | Barrington Research | Outperform | Outperform | Maintains |
| 2024-11-08 | Barrington Research | Outperform | Outperform | Maintains |
| 2024-10-03 | Barrington Research | Outperform | Outperform | Maintains |
| 2024-09-17 | Barrington Research | Outperform | Outperform | Maintains |
| 2024-09-17 | Lake Street | Buy | Buy | Maintains |
| 2024-09-13 | Jefferies | Hold | Hold | Maintains |
| 2024-08-09 | Barrington Research | Market Perform | Outperform | Upgrade |
| 2024-05-06 | Lake Street | Hold | Buy | Upgrade |
| 2024-02-26 | Barrington Research | Outperform | Market Perform | Downgrade |
| 2024-02-23 | Jefferies | Buy | Hold | Downgrade |
| 2024-02-23 | Deutsche Bank | Buy | Hold | Downgrade |
| 2023-11-06 | Barrington Research | Outperform | Outperform | Maintains |
| 2023-08-07 | Deutsche Bank | Buy | Buy | Maintains |
| 2023-08-07 | Barrington Research | Outperform | Outperform | Reiterate |
| 2023-06-27 | Stephens & Co. | Overweight | Overweight | Reiterate |
| 2023-06-06 | Stephens & Co. | Overweight | Overweight | Reiterate |
| 2023-05-05 | Stephens & Co. | Overweight | Maintains | |
| 2023-05-05 | Barrington Research | Outperform | Maintains | |
| 2023-02-24 | Deutsche Bank | Buy | Maintains | |
| 2023-02-24 | Barrington Research | Outperform | Maintains | |
| 2022-11-04 | Barrington Research | Outperform | Maintains | |
| 2022-08-03 | Stephens & Co. | Overweight | Initiate | |
| 2022-02-03 | Deutsche Bank | Buy | Maintains | |
| 2021-12-17 | Deutsche Bank | Buy | Initiate | |
| 2021-05-10 | Barrington Research | Outperform | Maintains |
